Europe
The U.K authorized AstraZeneca’s COVID-19 vaccine on Wednesday, but it could be April at the earliest before the drug will likely be administered in the United States, Operation Warp Speed’s chief said.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Overnight, U.K. health authorities authorized the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use.
The United Kingdom is expected to give the green light to the vaccine developed by AstraZeneca and Oxford University this week.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Even with the holidays among us, there were a number of clinical trial announcements. Here’s a look.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
An investigational asthma treatment, tezepelumab, under development by Amgen and AstraZeneca failed to reduce asthma patients’ dependence on corticosteroids.
The U.S. Food and Drug Administration has approved several drugs and medical devices in the last week. Here’s a look.
PRESS RELEASES